Understanding how T cell precursors develop into committed cells
Lmo2-Lyl1 and the bHLH factor network in pro-T cells
This study is looking at how early T cells develop in the thymus and what helps them grow and survive, which could help us understand T cell behavior better and how it relates to conditions like acute lymphoblastic leukemia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California Institute of Technology NIH-funded |
| Lab location | 1 site (Pasadena, United States) |
| Project ID | NIH-11092152 on NIH RePORTER |
What this research studies
This research investigates the early stages of T cell development, focusing on how T cell precursors transition from a multipotent state to a committed state in the thymus. It aims to uncover the genetic and molecular mechanisms that control this differentiation process, particularly the roles of specific proteins like Lmo2 and Lyl1. By analyzing the interactions of these proteins with other factors, the research seeks to clarify how these early cell cycles influence the survival and selection of pro-T cells. This could lead to a better understanding of T cell biology and its implications for conditions like acute lymphoblastic leukemia.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with acute lymphoblastic leukemia or those at risk of developing T cell-related malignancies.
Not a fit: Patients with other types of leukemia or those who do not have T cell-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating acute lymphoblastic leukemia by improving our understanding of T cell development.
How similar studies have performed: Other research has shown promising results in understanding T cell differentiation, suggesting that this approach could yield valuable insights.
Where this research is happening
Pasadena, United States
- California Institute of Technology — Pasadena, United States (Active)
Researchers
- Principal investigator: Rothenberg, Ellen V. — California Institute of Technology
- Study coordinator: Rothenberg, Ellen V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.